264 related articles for article (PubMed ID: 17312184)
1. C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis.
Jégou JF; Chan P; Schouft MT; Griffiths MR; Neal JW; Gasque P; Vaudry H; Fontaine M
J Immunol; 2007 Mar; 178(5):3323-31. PubMed ID: 17312184
[TBL] [Abstract][Full Text] [Related]
2. Protective DNA vaccination against myelin oligodendrocyte glycoprotein is overcome by C3d in experimental autoimmune encephalomyelitis.
Jégou JF; Chan P; Schouft MT; Gasque P; Vaudry H; Fontaine M
Mol Immunol; 2007 Jul; 44(15):3691-701. PubMed ID: 17521729
[TBL] [Abstract][Full Text] [Related]
3. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
Offen D; Kaye JF; Bernard O; Merims D; Coire CI; Panet H; Melamed E; Ben-Nun A
J Mol Neurosci; 2000 Dec; 15(3):167-76. PubMed ID: 11303781
[TBL] [Abstract][Full Text] [Related]
4. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
[TBL] [Abstract][Full Text] [Related]
5. Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.
Peterson LK; Tsunoda I; Libbey JE; Fujinami RS
Exp Mol Pathol; 2008 Aug; 85(1):28-39. PubMed ID: 18486939
[TBL] [Abstract][Full Text] [Related]
6. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
7. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
8. Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes.
Kerlero de Rosbo N; Brok HP; Bauer J; Kaye JF; 't Hart BA; Ben-Nun A
J Neuroimmunol; 2000 Oct; 110(1-2):83-96. PubMed ID: 11024537
[TBL] [Abstract][Full Text] [Related]
9. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
Lev N; Barhum Y; Melamed E; Offen D
Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
[TBL] [Abstract][Full Text] [Related]
10. Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.
Terényi N; Nagy N; Papp K; Prechl J; Oláh I; Erdei A
Mol Immunol; 2009 Nov; 47(1):57-63. PubMed ID: 19201476
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
12. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
Bernard CC; Johns TG; Slavin A; Ichikawa M; Ewing C; Liu J; Bettadapura J
J Mol Med (Berl); 1997 Feb; 75(2):77-88. PubMed ID: 9083925
[TBL] [Abstract][Full Text] [Related]
13. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Herrero-Herranz E; Pardo LA; Gold R; Linker RA
Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
[TBL] [Abstract][Full Text] [Related]
14. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide.
Lyons JA; San M; Happ MP; Cross AH
Eur J Immunol; 1999 Nov; 29(11):3432-9. PubMed ID: 10556797
[TBL] [Abstract][Full Text] [Related]
15. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
[TBL] [Abstract][Full Text] [Related]
16. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
[TBL] [Abstract][Full Text] [Related]
17. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
[TBL] [Abstract][Full Text] [Related]
18. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
19. B cell recognition of myelin oligodendrocyte glycoprotein autoantigen depends on immunization with protein rather than short peptide, while B cell invasion of the CNS in autoimmunity does not.
Dang AK; Jain RW; Craig HC; Kerfoot SM
J Neuroimmunol; 2015 Jan; 278():73-84. PubMed ID: 25595255
[TBL] [Abstract][Full Text] [Related]
20. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions.
Merkler D; Schmelting B; Czéh B; Fuchs E; Stadelmann C; Brück W
Mult Scler; 2006 Aug; 12(4):369-74. PubMed ID: 16900750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
